Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

AEON BIOPHARMA — Lobbying — Receipts Report

LD-2 disclosure · Registration

AEON BIOPHARMA

via FORBES-TATE

2nd Quarter (Apr 1 - June 30) · 2019Posted Jun 25, 2019Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: AEON BIOPHARMA
Description: Pharmaceutical Company
Location: California · United States of America

Registrant

Firm: FORBES-TATE
Description: Government Relations Firm.
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to Biologics
LobbyistsEDWARD C. RENO iii

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.